Gary C. Yee, Pharm.D., FCCP, BCOP

Professor and Associate Dean for Academic Affairs

College of Pharmacy
University of Nebraska Medical Center
986045 Nebraska Medical Center
Omaha, NE 68198-6045
402-559-2415 (Office)
402-559-5673 (Fax)
gcyee@unmc.edu
 
Teaching Activities:
Dr. Yee gives lectures in several team-taught courses, including Pharmacotherapy III (PHPR 688), Applied Biochemistry (BIOC 514), and other courses taught at UNMC. Dr. Yee is the primary instructor and course coordinator for Drug Literature Evaluation and Research Methods (PHPR 622), which is based on the principles of Evidence-Based Medicine. Finally, he serves as a preceptor for the Oncology clerkship.
 
Research Activities/Interests: 
Dr. Yee's primary research interests are in the cost and cost-effectiveness of drugs used in patients with cancer, particularly those undergoing hematopoietic stem cell transplantation. Other areas of expertise include managed care, biotechnology drugs, pharmacogenomics, biologic therapy, and oncology drugs.
 
Recent Publications: 

  1. Dipiro J, Talbert B, Yee GC, Matzke GR, Wells BG, Posey LM (eds.).  Pharmacotherapy: A Pathophysiologic Approach, 7th edition, New York, McGraw-Hill, 2008.
  2. Perkins J, Yee GC.  Hematopoietic stem cell transplantation.  In:  Pharmacotherapy:  A Pathophysiologic Approach, 7th edition, Dipiro J, Talbert B, Yee GC, Matzke GR, Wells BG, Posey LM (eds.). New York, McGraw-Hill, 2008, pp 2331-2348.    
  3. Adams VR, Yee GC.  Lymphomas.  In:  Pharmacotherapy: A Pathophysiologic Approach, 7th edition, Dipiro J, Talbert B, Yee GC, Matzke GR, Wells BG, Posey LM (eds.). New York, McGraw-Hill, 2008, pp 2219-2244.
  4. Hogeland GW, Swindells S, McNabb J, Kashuba ADM, Yee GC, Lindley CM.  Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects.  Clin Pharmacol Ther  2006; 81:69-75.
  5. Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, Jagannath S, Orlowski RZ, Roodman DG, Twilde P, Anderson K.  American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.  J Clin Oncol 2007; 25:2464-2472

Gary Yee, Pharm.D.
Dr. Yee